Choroid Plexus Enlargement and USPIO‐Based Inflammatory Feature in Cerebral Small Vessel Disease
ABSTRACT Objective The choroid plexus (CP) is a key component of the blood–cerebrospinal fluid barrier (BCSFB), but its mechanism of action in cerebral small vessel disease (CSVD) remains unclear. This study investigated CP volume (CPV) alterations and their association with conventional imaging markers in CSVD and explored the underlying role of ...
Yongqiang Qu +11 more
wiley +1 more source
Anisotropic Roughening of a Au(111) Single-Crystal Electrode Surface in HClO<sub>4</sub> Solution during Oxidation-Reduction Cycles. [PDF]
Behjati S +3 more
europepmc +1 more source
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
Effect of Trace Amounts of Chloride on Roughening of Au(111) Single-Crystal Electrode Surface in Sulfuric Acid Solution during Oxidation-Reduction Cycles. [PDF]
Behjati S, Koper MTM.
europepmc +1 more source
Transcriptome analysis of chloride intracellular channel knockdown in Drosophila identifies oxidation-reduction function as possible mechanism of altered sensitivity to ethanol sedation. [PDF]
Weston RM +3 more
europepmc +1 more source
Recurrent Hypothermia and Autonomic Dysfunction Secondary to Shapiro Syndrome
ABSTRACT A 44‐year‐old man presented with recurrent hypothermia, diaphoresis and hypertension. Extensive investigation for infectious, inflammatory, metabolic and endocrine aetiologies was negative. MR scan of the brain demonstrated no lesions but revealed callosal dysgenesis, consistent with Shapiro syndrome.
Naveen Kumar +3 more
wiley +1 more source
Oxidation-reduction imaging of myoglobin reveals two-phase oxidation in the reperfused myocardium. [PDF]
Badawi S +16 more
europepmc +1 more source
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source
In Situ STM Study of Roughening of Au(111) Single-Crystal Electrode in Sulfuric Acid Solution during Oxidation-Reduction Cycles. [PDF]
Behjati S, Koper MTM.
europepmc +1 more source
From photosynthesis to photocatalysis: Dual catalytic oxidation/reduction in one system. [PDF]
Chen LX.
europepmc +1 more source

